Merit Medical Systems price to free cash flow MMSI
Market value divided by free cash flow over the last twelve months, since 2014.
- Today, Oct 23, 2026
- 27.4×
- 10-year median
- 43.7×
- Against its 10-year history
- 16th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 16.6× to 331×
- Peer median
- 23.6×
Merit Medical Systems' price to free cash flow is 27.4× as of Oct 23, 2026.
That is below its ten-year median of 43.7×, lower than on 84% of days in the last ten years.
Over that time it ranged from 16.6× in May 2026 to 331× in Oct 2018.
The median for 10 medical instruments and supplies stocks of a similar size is 23.6×.
Price to free cash flow over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 27.4× | 16.6× | 27.4× |
| 2025 | 25.0× | 23.9× | 36.2× |
| 2024 | 32.3× | 28.7× | 64.8× |
| 2023 | 61.6× | 43.6× | 85.4× |
| 2022 | 44.1× | 28.1× | 45.6× |
| 2021 | 32.5× | 25.1× | 36.1× |
| 2020 | 31.0× | 28.5× | 131× |
| 2019 | 75.7× | 68.5× | 147× |
| 2018 | 116× | 86.4× | 331× |
| 2017 | 87.5× | 55.7× | 122× |
| 2016 | 109× | 23.7× | 141× |
| 2015 | 28.0× | 24.2× | 62.6× |
| 2014 | 55.4× | 47.0× | 82.7× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Merit Medical Systems' size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| MMSIMerit Medical Systems | 27.4× |
| HAEHaemonetics | 18.5× |
| VNTVontier | 12.1× |
| MSAMSA Safety | 19.8× |
| BMIBadger Meter | 29.2× |
| ICUIICU Medical | 27.3× |
| NVSTEnvista | 15.3× |
| WRBYWarby Parker | 147× |
| PODDInsulet | 35.2× |
| ATRCAtriCure | 56.5× |
| GMEDGlobus Medical | 14.5× |
| Peer median | 23.6× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Merit Medical Systems
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.